3.0900
-0.0100
(-0.32%)
At close: January 14 at 4:00:01 PM EST
3.0200
-0.07
(-2.27%)
After hours: January 14 at 4:42:21 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-55,167.0000
-43,753.0000
-49,044.0000
-35,157.0000
-25,957.0000
Investing Cash Flow
--
48,969.0000
--
--
25.0000
Financing Cash Flow
37,080.0000
-30.0000
-210.0000
98,035.0000
73,997.0000
End Cash Position
62,656.0000
70,643.0000
65,500.0000
114,916.0000
52,071.0000
Issuance of Capital Stock
--
--
--
97,222.0000
75,504.0000
Repurchase of Capital Stock
--
-1.0000
--
--
--
Free Cash Flow
-55,167.0000
-43,753.0000
-49,044.0000
-35,157.0000
-25,957.0000
12/31/2020 - 1/25/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CRVS Corvus Pharmaceuticals, Inc.
5.10
-1.92%
MREO Mereo BioPharma Group plc
3.0600
-8.38%
CLSD Clearside Biomedical, Inc.
0.9200
-1.03%
XLO Xilio Therapeutics, Inc.
1.0800
-1.82%
PDSB PDS Biotechnology Corporation
1.3900
-2.11%
ATXI Avenue Therapeutics, Inc.
1.8800
-1.05%
ATYR aTyr Pharma, Inc.
3.2900
0.00%
GOSS Gossamer Bio, Inc.
0.8484
-8.07%
ALXO ALX Oncology Holdings Inc.
1.5900
-5.92%
CNTX Context Therapeutics Inc.
0.9901
-3.87%